Literature DB >> 16353512

[Early postpartum hospital discharge in France].

F Vendittelli1, M Boniol, N Mamelle.   

Abstract

BACKGROUND: Early postpartum discharge is a recent practice in France and for which there are few national data.
METHODS: The Sentinel AUDIPOG network was used to describe the practice of postpartum early discharge (< 3 days in case of vaginal delivery and < 5 days in case of caesarean section) from 1994 till 2002, after standardization on the distribution according to the type of hospital and the region (n = 128232). Secondarily, the prognostic medical factors of an early postpartum hospital discharge were researched, in univariate analysis and logistic regression analysis, of the births of 2001-2002.
RESULTS: Early postpartum discharges concerned 3% of the deliveries in 1997 and 7% in 2002. Eearly postpartum discharge was more frequent in the level II and III obstetric facilities, in non- university hospitals, in facilities with more than 1 500 deliveries a year, in urban hospitals and in Paris and the surrounding area. The women leaving early in the postpartum were more often multiparas, with no pregnancy pathology, with a single pregnancy, without postpartum hemorrhage, and a child > 2500 g without risk of infection. At present, 40% of vaginal delivery and 25% of caesarean section primiparas and 55% of vaginal delivery and 30% of caesarean section multiparas could be discharged early.
CONCLUSION: The reduction of the postpartum hospital stay is inevitable but it is advisable to take care that the women who are discharged are medically fit for discharge.

Entities:  

Mesh:

Year:  2005        PMID: 16353512     DOI: 10.1016/s0398-7620(05)84619-x

Source DB:  PubMed          Journal:  Rev Epidemiol Sante Publique        ISSN: 0398-7620            Impact factor:   1.019


  1 in total

1.  Length of stay following cesarean sections: A population based study in the Friuli Venezia Giulia region (North-Eastern Italy), 2005-2015.

Authors:  Luca Cegolon; Giuseppe Mastrangelo; Oona M Campbell; Manuela Giangreco; Salvatore Alberico; Lorenzo Montasta; Luca Ronfani; Fabio Barbone
Journal:  PLoS One       Date:  2019-02-27       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.